期刊
AMERICAN JOURNAL OF MEDICINE
卷 122, 期 4, 页码 S4-S11出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2009.01.002
关键词
Cardiovascular disease; Health care costs; Lipoproteins; Metabolic syndrome; Obesity; Risk factor
资金
- GlaxoSmithKiine
- sanofi-aventis Pharmaceuticals, Inc
- Wyeth
The obesity epidemic in the United States represents a critical public health issue that has the potential to incur major healthcare costs because of the substantial risks associated with excess body fat. Whereas many recognize the significant risk of cardiovascular disease and diabetes mellitus associated with excess body fat, a myriad of other health problems can accompany overweight and obesity, potentially leading to early morbidity and mortality. Public recognition of obesity as an important health crisis, and not simply a matter of cosmetics or lifestyle choice, is clearly needed. A greater awareness of the health risks associated with excess weight will facilitate more frequent obesity screenings and discussions about healthy weight management that have the potential to result in a greater commitment of healthcare resources to effective obesity prevention and management strategies. (C) 2009 Published by Elsevier Inc. The American Journal of Medicine (2009) 122, S4-S11
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据